Cargando…

Obesity paradox and lung cancer, metformin-based therapeutic opportunity?

Detalles Bibliográficos
Autores principales:	Barrios-Bernal, Pedro, Hernández-Pedro, Norma, Lara-Mejía, Luis, Arrieta, Oscar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10317038/ https://www.ncbi.nlm.nih.gov/pubmed/37395790 http://dx.doi.org/10.18632/oncotarget.28432

Ejemplares similares

A Novel Combination of Sotorasib and Metformin Enhances Cytotoxicity and Apoptosis in KRAS-Mutated Non-Small Cell Lung Cancer Cell Lines through MAPK and P70S6K Inhibition
por: Barrios-Bernal, Pedro, et al.
Publicado: (2023)

Interplay between Cellular and Molecular Inflammatory Mediators in Lung Cancer
por: Orozco-Morales, Mario, et al.
Publicado: (2016)

Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Will We Unlock the Benefit of Metformin for Patients with Lung Cancer? Lessons from Current Evidence and New Hypotheses
por: Barrios-Bernal, Pedro, et al.
Publicado: (2022)

Radial First: Paradox+Proficiency=Opportunity
por: Rao, Sunil V., et al.
Publicado: (2013)

Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
por: Orozco-Morales, Mario, et al.
Publicado: (2021)

On the trail of the obesity paradox
por: Gladow, Nadine, et al.
Publicado: (2022)

Metformin and breast cancer: an opportunity for pharmacogenetics
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

Kidney disease and obesity paradox
por: Park, Jongha
Publicado: (2017)

Recognizing obesity as a disease: A true challenge()
por: Arrieta, F., et al.
Publicado: (2021)

Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer
por: Hernández-Pedro, Norma, et al.
Publicado: (2023)

The Obesity Paradox in Cancer: Is Bigger Better?
por: Laird, Barry J.A., et al.
Publicado: (2022)

Targeted next generation sequencing identified a high frequency genetic mutated profile in wood smoke exposure-related lung adenocarcinoma patients
por: Soca-Chafre, Giovanny, et al.
Publicado: (2018)

The Opportunity Paradox
por: Eisenhardt, Kathleen
Publicado: (2014)

The obesity paradox in chronic disease: facts and numbers
por: Lainscak, Mitja, et al.
Publicado: (2012)

“Obesity and Lean Paradox” in Peripheral Artery Disease
por: Lee, Seung Hun, et al.
Publicado: (2021)

The Obesity Paradox in Infections and Implications for COVID-19
por: Lavie, Carl J., et al.
Publicado: (2021)

The Paradox in Defining Obesity in Patients With Heart Failure
por: Kim, Se-Eun, et al.
Publicado: (2022)

Obesity and survival in critically ill patients with acute respiratory distress syndrome: a paradox within the paradox
por: Ball, Lorenzo, et al.
Publicado: (2017)

The Paradox of Obesity in Patients with Chronic Obstructive Pulmonary Disease
por: Yohannes, Abebaw Mengistu
Publicado: (2022)

Does Obesity Paradox Exist in COVID-19 Mortality?
por: Kim, JungHwan
Publicado: (2022)

The Obesity Paradox in Patients in Need of Extracorporeal Membrane Oxygenation
por: Pickkers, Peter
Publicado: (2023)

Association between CD47 expression, clinical characteristics and prognosis in patients with advanced non‐small cell lung cancer
por: Arrieta, Oscar, et al.
Publicado: (2020)

Coregulation of pathways in lung cancer patients with EGFR mutation: therapeutic opportunities
por: Rosell, Rafael, et al.
Publicado: (2021)

CD47-SIRPα Axis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
por: Catalán, Rodrigo, et al.
Publicado: (2020)

The obesity paradox in varicocele – is the protective effect real?
por: Esteves, Sandro C., et al.
Publicado: (2020)

LKB1 Loss Assessed by Immunohistochemistry as a Prognostic Marker to First-Line Therapy in Advanced Non-Small-Cell Lung Cancer
por: Avilés-Salas, Alejandro, et al.
Publicado: (2022)

Paradoxic effects of metformin on endothelial cells and angiogenesis
por: Dallaglio, Katiuscia, et al.
Publicado: (2014)

Role of Omentin in Obesity Paradox in Lung Cancer
por: Parida, Sheetal, et al.
Publicado: (2021)

Obesity Paradox in Lung Diseases: What Explains It?
por: Yao, Surui, et al.
Publicado: (2023)

The Australian Paradox
por: Howe, Peter
Publicado: (2012)

Metformin paradoxically worsens insulin resistance in SHORT syndrome
por: Lewandowski, Krzysztof C., et al.
Publicado: (2019)

The ‘French paradox’ may not be a paradox after all – but for what reason?
por: Clauss, M., et al.
Publicado: (2019)

EGFR Signaling in Non-Small Cell Lung Cancer: From Molecular Mechanisms to Therapeutic Opportunities
por: La Monica, Silvia
Publicado: (2022)

Is There Room for Paradox in CAM?
por: Cooper, Edwin L.
Publicado: (2007)

A Glaring Paradox
por: Johnston, Mark
Publicado: (2015)

Contemporary IP Paradoxes
por: Salomão Filho, Calixto
Publicado: (2022)

The Situation: A Paradox
Publicado: (1903)

Reconocer la obesidad como enfermedad: todo un reto
por: Arrieta, F., et al.
Publicado: (2021)

Obesity paradox in joint replacement for osteoarthritis — truth or paradox?
por: Kunutsor, Setor K., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_82s4695qfvdfdhm9g3l79u33me